TMCnet News

Research and Markets: This Essential Report on Israel's Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012 is Now Available
[November 25, 2008]

Research and Markets: This Essential Report on Israel's Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012 is Now Available


(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:25112008

Dublin - Research and Markets
(http://www.researchandmarkets.com/research/703907/israel_drug_delive)
has announced the addition of Global Markets Direct's new report
"Israel Drug Delivery Devices Investment Opportunities, Analysis and
Forecasts to 2012" to their offering.

Israel Drug Delivery Devices Investment Opportunities, Analysis and
Forecasts to 2012

Summary

This report is an essential source for in-depth information and data
relating to the Israel drug delivery devices market. It also offers
detailed and comprehensive coverage of market revenue, volume,
distribution and company share information; and latest news, financial
deals and pipeline products information of each of the key sub-segments
of the drug delivery devices in Israel

Scope

- The report provides drug delivery devices information broken down
into detailed categories and segments in Israel.

- Total revenues, products sold, end users, and average pricing.

- Market shares of all the key competitors.

- Key pipeline products that are set to shape the market, broken down
by sector.

- Information on the top medical equipment companies in the sector in
the country covering business description, strategic analysis, and
financial information.

- Healthcare structure, regulatory environment, approval process,
pricing trends and reimbursement.

- Product and brand updates, strategy changes, R&D projects, corporate
expansions and contractions and regulatory changes.

- Key mergers and acquisitions, partnerships, private equity
investments and IPOs.

- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the drug delivery devices market in
Israel.

- Evaluate and compare the attractiveness of the market in the country.

- Identify growth segments and opportunities in each industry sector
within the country.

- Evaluate the pipeline of key products that will change the sector,
and identify threats and opportunities before the products are launched
in the country.

- Analyze the competitiveness of the market in the country and identify
hotspots.

- Develop strategies based on the latest product, brand, expansion and
research and development news in the country.

- Do deals with an understanding of how competitors are financed, and
the mergers and partnerships that have shaped the market in the country.

- Identify and analyze the strengths and weaknesses of the industry
incumbents in the country.

Key Topics Covered:

- Introduction

- Definitions of the Markets Covered in the Report

- Healthcare Sector Review

- Regulation System

- Pricing and Reimbursement


- Distribution Structure

- Drug Delivery Devices In Israel

- Infusion Systems In Israel

- Inhalation Systems In Israel

- APPENDIX

Companies Mentioned:

-AstraZeneca PLC

-3M Company

-GlaxoSmithKline plc

-Novartis Medical Nutrition

-Cardinal Health, Inc.

-Baxter International Inc.

-E-Pill Pharma Ltd.

-Maya Biotech Ltd.

-Meytav Technological Incubator

-NanoPass Technologies Ltd.

-NeuroDerm Ltd.

-OcuPharma Ltd.

-ORADEL MEDICAL LTD.

-RescueDose L.T.D.

-SONENCO LTD.

-SteadyMed Ltd.

-Unique Flow Ltd.

For more information visit
http://www.researchandmarkets.com/research/703907/israel_drug_delive

CONTACT: Laura Wood, Senior Manager, Research and Markets
Fax: +1 646 607 1907 (US)
Fax: +353 1 481 1716 (Rest of World)
e-mail: [email protected]

((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
[email protected])).

Copyright ? 2008 M2 Communications Ltd.

[ Back To TMCnet.com's Homepage ]